1. Home
  2. POAI vs SONM Comparison

POAI vs SONM Comparison

Compare POAI & SONM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • SONM
  • Stock Information
  • Founded
  • POAI 2002
  • SONM 1999
  • Country
  • POAI United States
  • SONM United States
  • Employees
  • POAI N/A
  • SONM N/A
  • Industry
  • POAI Industrial Specialties
  • SONM Telecommunications Equipment
  • Sector
  • POAI Health Care
  • SONM Telecommunications
  • Exchange
  • POAI Nasdaq
  • SONM Nasdaq
  • Market Cap
  • POAI 8.9M
  • SONM 10.2M
  • IPO Year
  • POAI N/A
  • SONM 2019
  • Fundamental
  • Price
  • POAI $0.89
  • SONM $1.49
  • Analyst Decision
  • POAI Hold
  • SONM
  • Analyst Count
  • POAI 1
  • SONM 0
  • Target Price
  • POAI N/A
  • SONM N/A
  • AVG Volume (30 Days)
  • POAI 93.9K
  • SONM 11.6M
  • Earning Date
  • POAI 08-12-2025
  • SONM 08-08-2025
  • Dividend Yield
  • POAI N/A
  • SONM N/A
  • EPS Growth
  • POAI N/A
  • SONM N/A
  • EPS
  • POAI N/A
  • SONM N/A
  • Revenue
  • POAI $1,729,269.00
  • SONM $58,243,000.00
  • Revenue This Year
  • POAI $486.27
  • SONM $127.68
  • Revenue Next Year
  • POAI $65.50
  • SONM N/A
  • P/E Ratio
  • POAI N/A
  • SONM N/A
  • Revenue Growth
  • POAI 24.17
  • SONM N/A
  • 52 Week Low
  • POAI $0.55
  • SONM $0.85
  • 52 Week High
  • POAI $3.06
  • SONM $10.50
  • Technical
  • Relative Strength Index (RSI)
  • POAI 38.00
  • SONM 59.58
  • Support Level
  • POAI $0.85
  • SONM $0.97
  • Resistance Level
  • POAI $0.91
  • SONM $2.08
  • Average True Range (ATR)
  • POAI 0.06
  • SONM 0.30
  • MACD
  • POAI -0.00
  • SONM 0.06
  • Stochastic Oscillator
  • POAI 4.12
  • SONM 58.23

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

Share on Social Networks: